Assessing Abbott Laboratories (ABT) Valuation After Libre Assist Expands Its Digital Diabetes Offering [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
See our latest analysis for Abbott Laboratories. The Libre Assist launch comes as Abbott's 1 month share price return sits at 4.07% and its year to date share price return is 1.60%, while the 1 year total shareholder return of 12.53% points to steady momentum rather than a sharp re rating. If Libre Assist has you rethinking digital health opportunities, it could be a good moment to scan other healthcare stocks that are trying to reshape how care is delivered. With shares up 4.07% over the past month and trading at $126.18, while sitting at a 14.75% discount to the average analyst target, is Abbott quietly offering an entry point, or is the market already baking in Libre driven growth? With Abbott Laboratories last closing at $126.18 versus a narrative fair value of about $144.43, the valuation hinges on how durable its earnings power really is. The analysts have a consensus price target of $142.485 for Abbott Laboratories based on their expectations of its future earnings g
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- 3 Analyst-Approved Stocks With Fat Yields That Could Rally 27% or More [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (ABT) had its price target lowered by Citigroup Inc. from $140.00 to $136.00. They now have a "buy" rating on the stock.MarketBeat
- Why Abbott (ABT) is a Top Value Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
- Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team' [Yahoo! Finance]Yahoo! Finance
- Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team'PR Newswire
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 3/9/26 - Form 8-K
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- ABT's page on the SEC website